Nektar Therapeutics
Clinical trials sponsored by Nektar Therapeutics, explained in plain language.
-
New eczema drug shows promise in Mid-Stage trial
Disease control OngoingThis study tests an experimental drug called rezpegaldesleukin for adults with moderate-to-severe atopic dermatitis (eczema). About 396 participants will receive either the drug or a placebo for 16 weeks, and those who respond may continue treatment for up to a year. The goal is …
Phase: PHASE2 • Sponsor: Nektar Therapeutics • Aim: Disease control
Last updated May 26, 2026 10:58 UTC
-
New drug aims to regrow hair in severe alopecia
Disease control OngoingThis study tests an experimental drug called rezpegaldesleukin for adults with severe to very severe alopecia areata, a condition causing significant hair loss. About 94 participants will receive either the drug or a placebo to see if it helps regrow hair over 36 weeks, with an o…
Phase: PHASE2 • Sponsor: Nektar Therapeutics • Aim: Disease control
Last updated May 26, 2026 10:57 UTC